Curis, Inc. strengthens executive team with appointment of industry veteran Jonathan Zung, Ph.D. as Chief Development Officer on May 1, 2023. Dr. Zung is a well-respected leader in the industry and brings a wealth of experience from senior roles across the industry, most recently at Evelo. Prior to joining Curis, he served as CDO of Evelo Biosciences, where he was responsible for the operational design and execution of Evelo's clinical programs. Dr. Zung held previous leadership roles at WCG, Covance, UCB, Bristol Myers Squibb, and Pfizer.

He also serves on the advisory board of Saama Technologies. He received his Ph.D. in analytical chemistry from Emory University.